KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Tax Provisions (2018 - 2025)

Vir Biotechnology's Tax Provisions history spans 8 years, with the latest figure at -$137000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions fell 59.3% year-over-year to -$137000.0; the TTM value through Dec 2025 reached $217000.0, up 118.95%, while the annual FY2025 figure was $217000.0, 118.95% up from the prior year.
  • Tax Provisions for Q4 2025 was -$137000.0 at Vir Biotechnology, down from $168000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $403.3 million in Q1 2022 and bottomed at -$157.2 million in Q2 2022.
  • The 5-year median for Tax Provisions is $34500.0 (2021), against an average of $12.3 million.
  • The largest YoY upside for Tax Provisions was 205658.16% in 2022 against a maximum downside of 296756.6% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $20.6 million in 2021, then crashed by 342.48% to -$50.0 million in 2022, then surged by 90.44% to -$4.8 million in 2023, then skyrocketed by 98.2% to -$86000.0 in 2024, then tumbled by 59.3% to -$137000.0 in 2025.
  • Per Business Quant, the three most recent readings for VIR's Tax Provisions are -$137000.0 (Q4 2025), $168000.0 (Q3 2025), and $170000.0 (Q2 2025).